Anavo Therapeutics GmbH

Pursuing a Career in Phosphatase Drug Discovery Anavo Therapeutics is leading the space in phosphatase-targeted drug discovery and development.

To expand our reach across Europe, we have established a new R&D Hub based in Heidelberg, a flourishing center for both academic and cancer research, in addition to our headquarters in Leiden, The Netherlands. With proximity to the German Cancer Research Center, the European Molecular Biology Laboratory, and several universities and research organizations, Anavo leverages access to top-tier resources to aid in the advancement of our proprietary IGNITE platform.